NCT03541980View on ClinicalTrials.gov

Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Sickle Cell Anemia Crisis
Interventions
DRUG

Acetaminophen

Administration of 15 mg/kg (1000 mg max dose) of IV acetaminophen

DRUG

Normal saline

Normal saline volume equivalent

Trial Locations (1)

07112

Newark Beth Israel, Newark

All Listed Sponsors
lead

Newark Beth Israel Medical Center

OTHER

NCT03541980 - Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises? | Biotech Hunter | Biotech Hunter